HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer

Abstract

Rare high-level amplifications of therapeutic target genes were found in patients with colon cancer. Although no molecular differences were found between incidences of colon cancer cases in Swiss and Saudi populations, these observations emphasise the urgent need for clinical studies investigating the effect of targeted therapies.